PriceTargets.com logo

HCA Healthcare - HCA Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $474.53
  • Forecasted Upside: -2.70%
  • Number of Analysts: 24
  • Breakdown:
  • 0 Sell Ratings
  • 10 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$487.71 As of 12/4/2025 04:59 PM ET
▲ +0.936 (0.19%)

This chart shows the closing price for HCA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New HCA Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HCA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCA

Analyst Price Target is $474.53
▼ -2.70% Downside Potential
This price target is based on 24 analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $474.53, with a high forecast of $525.00 and a low forecast of $370.00. The average price target represents a -2.70% upside from the last price of $487.71.

This chart shows the closing price for HCA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 24 contributing investment analysts is to moderate buy stock in HCA Healthcare. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 13 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 2 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 2 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2024
  • 2 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
3/9/2025
  • 2 strong buy ratings
  • 11 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 7 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 14 buy ratings
  • 10 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 14 buy ratings
  • 10 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 10 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/27/2025Zacks ResearchDowngradeStrong-Buy ➝ Hold
11/24/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/17/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/13/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$412.00 ➝ $431.00
10/29/2025Zacks ResearchUpgradeHold ➝ Strong-Buy
10/28/2025Jefferies Financial GroupBoost TargetBuy ➝ Buy$485.00 ➝ $525.00
10/27/2025CowenReiterated RatingBuy ➝ Buy
10/27/2025BarclaysBoost TargetOverweight ➝ Overweight$445.00 ➝ $494.00
10/27/2025UBS GroupBoost TargetBuy ➝ Buy$495.00 ➝ $525.00
10/27/2025Morgan StanleySet Target$425.00
10/27/2025The Goldman Sachs GroupBoost TargetBuy ➝ Buy$470.00 ➝ $520.00
10/27/2025Raymond James FinancialSet Target$525.00
10/27/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight
10/27/2025Sanford C. BernsteinReiterated RatingMarket Perform ➝ Market Perform$417.00
10/27/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$430.00 ➝ $470.00
10/27/2025TD CowenBoost TargetBuy ➝ Buy$380.00 ➝ $490.00
10/27/2025Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$449.00 ➝ $482.00
10/27/2025StephensBoost TargetOverweight ➝ Overweight$450.00 ➝ $500.00
10/27/2025Truist FinancialBoost TargetBuy ➝ Buy$460.00 ➝ $495.00
10/27/2025MizuhoBoost TargetOutperform ➝ Outperform$475.00 ➝ $505.00
10/27/2025OppenheimerBoost TargetOutperform ➝ Outperform$400.00 ➝ $500.00
10/27/2025KeyCorpBoost TargetOverweight ➝ Overweight$465.00 ➝ $475.00
10/17/2025MizuhoBoost TargetOutperform ➝ Outperform$425.00 ➝ $475.00
10/15/2025Jefferies Financial GroupBoost Target$400.00 ➝ $485.00
10/14/2025Truist FinancialSet Target$460.00
10/14/2025UBS GroupBoost TargetBuy ➝ Buy$438.00 ➝ $495.00
10/14/2025The Goldman Sachs GroupInitiated CoverageBuy$470.00
10/14/2025The Goldman Sachs GroupInitiated CoverageBuy$470.00
10/8/2025KeyCorpBoost TargetOverweight ➝ Overweight$370.00 ➝ $465.00
10/8/2025UBS GroupSet Target$465.00
10/8/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
10/7/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$375.00 ➝ $412.00
10/7/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$444.00
9/27/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
9/18/2025BarclaysBoost TargetOverweight ➝ Overweight$390.00 ➝ $445.00
9/10/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$375.00 ➝ $410.00
8/26/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$444.00
8/14/2025Robert W. BairdBoost TargetNeutral ➝ Neutral$380.00 ➝ $423.00
8/14/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$385.00 ➝ $375.00
8/4/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$360.00 ➝ $370.00
7/28/2025Wolfe ResearchDowngradeOutperform ➝ Peer Perform
7/28/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$404.00 ➝ $401.00
7/28/2025BarclaysLower TargetOverweight ➝ Overweight$416.00 ➝ $390.00
7/28/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$410.00 ➝ $400.00
7/16/2025Truist FinancialBoost TargetBuy ➝ Buy$390.00 ➝ $415.00
7/16/2025Bank of AmericaDowngradeBuy ➝ Neutral$394.00
6/23/2025Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$376.00 ➝ $404.00
6/9/2025Morgan StanleySet TargetEqual Weight ➝ Equal Weight$355.00 ➝ $410.00
6/2/2025StephensUpgradeStrong-Buy
6/2/2025BarclaysSet TargetOverweight ➝ Overweight$366.00 ➝ $416.00
5/29/2025Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$320.00 ➝ $385.00
4/28/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$384.00 ➝ $376.00
4/15/2025Baird R WDowngradeStrong-Buy ➝ Hold
4/15/2025Robert W. BairdReiterated RatingOutperform ➝ Neutral$396.00 ➝ $336.00
4/9/2025GuggenheimInitiated CoverageNeutral
1/27/2025Bank of AmericaLower TargetBuy ➝ Buy$380.00 ➝ $370.00
1/27/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$405.00 ➝ $384.00
1/27/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$405.00 ➝ $405.00
1/27/2025BarclaysLower TargetOverweight ➝ Overweight$392.00 ➝ $366.00
1/7/2025KeyCorpLower TargetOverweight ➝ Overweight$420.00 ➝ $370.00
1/6/2025Truist FinancialLower TargetBuy ➝ Buy$430.00 ➝ $390.00
12/17/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$406.00 ➝ $355.00
12/17/2024JPMorgan Chase & Co.Reiterated RatingNeutral$380.00
11/25/2024Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$400.00 ➝ $320.00
11/22/2024Raymond James FinancialDowngradeOutperform ➝ Market Perform
11/8/2024BarclaysLower TargetOverweight ➝ Overweight$396.00 ➝ $392.00
11/6/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$395.00 ➝ $400.00
10/28/2024TD CowenLower TargetBuy ➝ Buy$450.00 ➝ $440.00
10/28/2024OppenheimerBoost TargetOutperform ➝ Outperform$390.00 ➝ $400.00
10/28/2024KeyCorpLower TargetOverweight ➝ Overweight$475.00 ➝ $420.00
10/22/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$365.00 ➝ $395.00
10/11/2024KeyCorpInitiated CoverageOverweight$475.00
10/10/2024KeyCorpUpgradeStrong-Buy
10/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$392.00 ➝ $392.00
9/3/2024Morgan StanleyInitiated CoverageEqual Weight$427.00
8/29/2024Wolfe ResearchUpgradeStrong-Buy
8/23/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$378.00 ➝ $405.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$392.00 ➝ $392.00
8/19/2024Truist FinancialBoost TargetBuy ➝ Buy$390.00 ➝ $430.00
8/14/2024UBS GroupBoost TargetBuy ➝ Buy$405.00 ➝ $438.00
7/30/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$315.00 ➝ $365.00
7/24/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$335.00 ➝ $335.00
7/24/2024BarclaysBoost TargetOverweight ➝ Overweight$376.00 ➝ $396.00
7/24/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$329.00 ➝ $378.00
7/24/2024Leerink PartnersBoost TargetOutperform ➝ Outperform$367.00 ➝ $396.00
7/24/2024OppenheimerBoost TargetOutperform ➝ Outperform$345.00 ➝ $390.00
7/24/2024Truist FinancialBoost TargetBuy ➝ Buy$375.00 ➝ $390.00
7/10/2024BarclaysBoost TargetOverweight ➝ Overweight$367.00 ➝ $376.00
7/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$335.00 ➝ $335.00
7/2/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$335.00 ➝ $335.00
6/28/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$359.00 ➝ $375.00
5/30/2024Baird R WUpgradeStrong-Buy
5/30/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$327.00 ➝ $332.00
5/30/2024Robert W. BairdInitiated CoverageOutperform$396.00
4/30/2024TD CowenLower TargetBuy ➝ Buy$371.00 ➝ $360.00
4/29/2024BarclaysBoost TargetOverweight ➝ Overweight$356.00 ➝ $367.00
4/29/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$322.00 ➝ $329.00
4/29/2024OppenheimerBoost TargetOutperform ➝ Outperform$330.00 ➝ $345.00
4/12/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$330.00 ➝ $359.00
4/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$335.00
3/28/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$303.00 ➝ $315.00
3/6/2024BarclaysInitiated CoverageOverweight$356.00
3/5/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$335.00
1/31/2024Truist FinancialBoost TargetBuy ➝ Buy$320.00 ➝ $345.00
1/31/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$308.00 ➝ $322.00
1/31/2024Raymond James FinancialBoost TargetOutperform ➝ Outperform$300.00 ➝ $330.00
1/24/2024Raymond James FinancialBoost TargetOutperform ➝ Outperform$280.00 ➝ $300.00
1/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$315.00
1/17/2024OppenheimerReiterated RatingOutperform ➝ Outperform$315.00
1/4/2024Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$277.00 ➝ $301.00
12/11/2023The Goldman Sachs GroupDowngradeBuy ➝ Neutral$271.00
11/17/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$313.00 ➝ $265.00
11/10/2023StephensReiterated RatingOverweight ➝ Overweight$280.00
10/30/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$329.00 ➝ $281.00
10/26/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$267.00 ➝ $254.00
10/25/2023Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$315.00 ➝ $284.00
10/25/2023Truist FinancialLower TargetBuy ➝ Buy$340.00 ➝ $300.00
10/25/2023MizuhoLower TargetBuy ➝ Buy$325.00 ➝ $275.00
10/25/2023CitigroupLower TargetBuy ➝ Buy$324.00 ➝ $279.00
10/25/2023StephensLower TargetOverweight ➝ Overweight$300.00 ➝ $280.00
10/25/2023Raymond James FinancialLower TargetOutperform ➝ Outperform$320.00 ➝ $280.00
10/20/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$275.00 ➝ $267.00
10/10/2023Sanford C. BernsteinLower Target$345.00 ➝ $294.00
9/14/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$315.00
9/13/2023Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$315.00
7/28/2023Credit Suisse GroupBoost TargetOutperform$311.00 ➝ $316.00
7/28/2023OppenheimerBoost TargetOutperform$310.00 ➝ $315.00
7/11/2023MizuhoBoost Target$305.00 ➝ $325.00
6/28/20231-800 FLOWERS.COMReiterated RatingMaintains
6/28/2023VNET GroupReiterated RatingMaintains
6/28/2023BarclaysBoost Target$275.00 ➝ $300.00
6/20/2023Truist FinancialBoost Target$325.00 ➝ $340.00
5/16/2023MizuhoBoost Target$298.00 ➝ $305.00
5/10/2023ArgusBoost Target$285.00 ➝ $310.00
4/25/2023Wells Fargo & CompanyBoost Target$243.00 ➝ $275.00
4/25/2023Sanford C. BernsteinBoost Target$310.00 ➝ $345.00
4/24/2023BarclaysBoost Target$256.00 ➝ $275.00
4/24/2023Truist FinancialBoost Target$310.00 ➝ $325.00
4/24/2023Royal Bank Of CanadaBoost Target$283.00 ➝ $315.00
4/24/2023Jefferies Financial GroupBoost Target$325.00 ➝ $350.00
4/24/2023Deutsche Bank AktiengesellschaftBoost Target$280.00 ➝ $310.00
4/24/2023Loop CapitalBoost Target$285.00 ➝ $320.00
4/24/2023Bank of AmericaBoost Target$294.00 ➝ $323.00
4/24/2023Raymond James FinancialBoost Target$300.00 ➝ $320.00
4/24/2023Credit Suisse GroupBoost Target$282.00 ➝ $311.00
4/24/2023OppenheimerBoost Target$270.00 ➝ $310.00
4/24/2023CitigroupBoost Target$293.00 ➝ $324.00
4/21/2023StephensReiterated RatingOverweight$283.00
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$304.00
4/19/2023JPMorgan Chase & Co.Boost TargetNeutral$257.00 ➝ $283.00
4/11/2023MizuhoBoost TargetBuy$279.00 ➝ $298.00
3/16/2023Royal Bank Of CanadaReiterated RatingOutperform$283.00
3/13/2023StephensReiterated RatingOverweight$283.00
2/23/2023JPMorgan Chase & Co.Boost TargetOverweight$235.00 ➝ $257.00
2/22/2023StephensBoost TargetOverweight$275.00 ➝ $283.00
2/13/2023ArgusBoost TargetBuy$260.00 ➝ $285.00
2/8/2023The Goldman Sachs GroupBoost TargetBuy$265.00 ➝ $296.00
1/31/2023Raymond James FinancialBoost TargetOutperform$230.00 ➝ $300.00
1/30/2023Loop CapitalBoost Target$240.00 ➝ $285.00
1/30/2023Royal Bank Of CanadaBoost TargetOutperform$239.00 ➝ $283.00
1/30/2023Truist FinancialBoost TargetBuy$270.00 ➝ $290.00
1/30/2023CowenBoost TargetOutperform$238.00 ➝ $292.00
1/30/2023MizuhoBoost TargetBuy$265.00 ➝ $279.00
1/30/2023CitigroupBoost TargetBuy$280.00 ➝ $293.00
1/19/2023OppenheimerBoost TargetOutperform$235.00 ➝ $270.00
1/13/2023UBS GroupBoost TargetBuy$237.00 ➝ $296.00
1/3/2023Wells Fargo & CompanyBoost TargetEqual Weight$217.00 ➝ $243.00
1/3/2023Truist FinancialBoost Target$240.00 ➝ $270.00
1/3/2023Deutsche Bank AktiengesellschaftBoost Target$240.00 ➝ $275.00
12/16/2022Leerink PartnersBoost TargetOutperform$238.00 ➝ $286.00
12/14/2022MizuhoBoost TargetBuy$242.00 ➝ $265.00
12/12/2022The Goldman Sachs GroupBoost TargetBuy$233.00 ➝ $265.00
11/2/2022MizuhoBoost TargetBuy$230.00 ➝ $242.00
10/27/2022Credit Suisse GroupLower Target$240.00
10/26/2022CitigroupBoost TargetBuy$240.00 ➝ $251.00
10/25/2022Raymond James FinancialLower TargetOutperform$250.00 ➝ $230.00
10/24/2022StephensLower TargetOverweight$230.00 ➝ $220.00
10/24/2022Royal Bank Of CanadaLower TargetOutperform$249.00 ➝ $239.00
10/24/2022Leerink PartnersLower TargetOutperform$252.00 ➝ $238.00
10/24/2022OppenheimerLower TargetOutperform$255.00 ➝ $235.00
10/24/2022Wells Fargo & CompanyBoost TargetEqual Weight$199.00 ➝ $217.00
9/16/2022Raymond James FinancialBoost TargetOutperform$230.00 ➝ $250.00
8/24/2022Leerink PartnersBoost TargetOutperform$240.00 ➝ $259.00
8/2/2022MizuhoBoost TargetBuy$210.00 ➝ $230.00
7/26/2022UBS GroupBoost Target$227.00
7/26/2022CitigroupLower Target$254.00 ➝ $240.00
7/25/2022StephensBoost Target$230.00
7/25/2022CowenLower Target$238.00
7/25/2022Credit Suisse GroupBoost TargetOutperform$230.00 ➝ $250.00
7/25/2022Leerink PartnersBoost TargetOutperform$212.00 ➝ $240.00
7/25/2022Truist FinancialBoost TargetBuy$208.00 ➝ $240.00
7/24/2022Bank of AmericaBoost Target$192.00 ➝ $230.00
7/19/2022Credit Suisse GroupSet Target$230.00
7/15/2022Leerink PartnersLower TargetOutperform$273.00 ➝ $212.00
7/12/2022The Goldman Sachs GroupLower TargetBuy$270.00 ➝ $233.00
7/11/2022Raymond James FinancialLower TargetOutperform$245.00 ➝ $220.00
7/7/2022Deutsche Bank AktiengesellschaftLower TargetBuy$306.00 ➝ $200.00
7/6/2022BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$233.00 ➝ $160.00
7/1/2022MizuhoLower TargetBuy$260.00 ➝ $210.00
6/21/2022Royal Bank Of CanadaLower TargetOutperform$267.00 ➝ $256.00
6/20/2022OppenheimerSet Target$255.00
6/16/2022Loop CapitalInitiated CoverageBuy$240.00
5/26/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$273.00 ➝ $271.00
5/3/2022MizuhoLower Target$290.00 ➝ $260.00
4/26/2022BMO Capital MarketsLower Target$275.00 ➝ $240.00
4/26/2022Raymond James FinancialLower TargetOutperform$275.00 ➝ $245.00
4/26/2022UBS GroupLower TargetBuy$289.00 ➝ $241.00
4/25/2022CowenLower Target$265.00 ➝ $241.00
4/25/2022Truist FinancialLower TargetBuy$310.00 ➝ $250.00
4/25/2022Jefferies Financial GroupLower Target$310.00 ➝ $275.00
4/25/2022Wells Fargo & CompanyLower TargetEqual Weight$267.00 ➝ $227.00
4/25/2022CowenLower Target$265.00 ➝ $241.00
4/25/2022Leerink PartnersLower TargetOutperform$304.00 ➝ $273.00
4/25/2022Royal Bank Of CanadaLower TargetOutperform$291.00 ➝ $267.00
4/25/2022CitigroupLower TargetBuy$277.00 ➝ $254.00
4/25/2022Credit Suisse GroupLower TargetOutperform$296.00 ➝ $260.00
3/28/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$267.00
1/28/2022CowenLower TargetOutperform$302.00 ➝ $265.00
1/28/2022Leerink PartnersLower TargetOutperform$320.00 ➝ $304.00
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$290.00 ➝ $310.00
12/21/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$270.00
12/20/2021MizuhoBoost TargetBuy$275.00 ➝ $290.00
10/26/2021Raymond James FinancialBoost TargetOutperform$290.00 ➝ $300.00
10/25/2021William BlairReiterated RatingMarket Perform
10/25/2021StephensBoost TargetOverweight$275.00 ➝ $283.00
10/25/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$275.00 ➝ $306.00
10/25/2021CitigroupBoost TargetNeutral$268.00 ➝ $274.00
10/25/2021Royal Bank Of CanadaBoost TargetOutperform$273.00 ➝ $291.00
10/25/2021Credit Suisse GroupBoost TargetOutperform$267.00 ➝ $298.00
10/25/2021OppenheimerBoost TargetOutperform$275.00 ➝ $290.00
9/27/2021Leerink PartnersInitiated CoverageOutperform$320.00
9/23/2021UBS GroupInitiated CoverageBuy$312.00
9/9/2021CowenInitiated CoverageOutperform$293.00
8/27/2021BarclaysReiterated RatingHold ➝ Neutral
8/12/2021BarclaysDowngradeOverweight ➝ Equal Weight$275.00 ➝ $267.00
8/6/2021The Goldman Sachs GroupBoost TargetBuy$252.00 ➝ $279.00
7/22/2021BarclaysBoost TargetOverweight$225.00 ➝ $275.00
7/21/2021Truist FinancialBoost TargetBuy$260.00 ➝ $290.00
7/21/2021Credit Suisse GroupBoost TargetOutperform$222.00 ➝ $267.00
7/21/2021MizuhoBoost TargetBuy$232.00 ➝ $275.00
7/21/2021Raymond James FinancialBoost TargetOutperform$225.00 ➝ $290.00
7/21/2021Royal Bank Of CanadaBoost TargetOutperform$247.00 ➝ $273.00
7/21/2021OppenheimerBoost TargetOutperform$230.00 ➝ $275.00
7/21/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$225.00 ➝ $275.00
7/21/2021BMO Capital MarketsBoost TargetMarket Perform$235.00 ➝ $250.00
7/21/2021CitigroupBoost TargetNeutral$215.00 ➝ $268.00
7/19/2021The Goldman Sachs GroupBoost TargetBuy$223.00 ➝ $252.00
7/9/2021Seaport Res PtnReiterated RatingBuy
6/18/2021Jefferies Financial GroupReiterated RatingBuy
4/29/2021Raymond James FinancialReiterated RatingOutperform$190.00 ➝ $225.00
4/29/2021Royal Bank Of CanadaBoost TargetOutperform$205.00 ➝ $232.00
4/29/2021MizuhoBoost TargetBuy$205.00 ➝ $232.00
4/26/2021CitigroupDowngradeBuy ➝ Neutral
4/26/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$210.00 ➝ $225.00
4/26/2021BMO Capital MarketsBoost TargetMarket Perform$200.00 ➝ $222.00
4/23/2021Raymond James FinancialBoost TargetOutperform$190.00 ➝ $225.00
4/23/2021OppenheimerBoost TargetOutperform$200.00 ➝ $230.00
4/23/2021BarclaysBoost TargetOverweight$195.00 ➝ $225.00
4/23/2021MizuhoBoost TargetBuy$205.00 ➝ $232.00
4/23/2021Royal Bank Of CanadaBoost TargetOutperform$205.00 ➝ $232.00
4/19/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$210.00 ➝ $225.00
4/14/2021Truist FinancialBoost TargetBuy$200.00 ➝ $230.00
4/13/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$180.00 ➝ $210.00
4/9/2021MizuhoBoost TargetBuy$195.00 ➝ $205.00
2/5/2021MizuhoBoost TargetBuy$180.00 ➝ $195.00
2/4/2021UBS GroupBoost TargetBuy$164.00 ➝ $203.00
2/3/2021CitigroupBoost Target$185.00 ➝ $191.00
2/3/2021Credit Suisse GroupBoost TargetOutperform$197.00 ➝ $201.00
2/3/2021Raymond James FinancialBoost TargetOutperform$150.00 ➝ $190.00
1/5/2021Truist FinancialBoost Target$165.00 ➝ $190.00
1/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$150.00 ➝ $180.00
12/18/2020MizuhoBoost TargetBuy$170.00 ➝ $180.00
12/15/2020The Goldman Sachs GroupInitiated CoverageBuy$191.00
12/14/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$143.00 ➝ $194.00
12/7/2020MizuhoBoost TargetBuy$150.00 ➝ $170.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.30 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 25 very positive mentions
  • 8 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 109 very positive mentions
  • 60 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
Mentions as of
11/4/2025
  • 133 very positive mentions
  • 39 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 133 very positive mentions
  • 39 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

HCA Healthcare logo
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $487.71
Low: $483.39
High: $491.56

50 Day Range

MA: $458.64
Low: $410.71
High: $515.89

52 Week Range

Now: $487.71
Low: $289.98
High: $520.00

Volume

1,633,362 shs

Average Volume

1,287,458 shs

Market Capitalization

$111.29 billion

P/E Ratio

18.85

Dividend Yield

0.59%

Beta

1.36

Frequently Asked Questions

What sell-side analysts currently cover shares of HCA Healthcare?

The following sell-side analysts have issued research reports on HCA Healthcare in the last year: Baird R W, Bank of America Corporation, Barclays PLC, Cantor Fitzgerald, Cowen Inc, Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Oppenheimer Holdings, Inc., Raymond James Financial, Inc., Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, Stephens, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Corporation, UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, Wolfe Research, and Zacks Research.
View the latest analyst ratings for HCA.

What is the current price target for HCA Healthcare?

0 Wall Street analysts have set twelve-month price targets for HCA Healthcare in the last year. Their average twelve-month price target is $474.53, suggesting a possible downside of 3.3%. UBS Group AG has the highest price target set, predicting HCA will reach $525.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $370.00 for HCA Healthcare in the next year.
View the latest price targets for HCA.

What is the current consensus analyst rating for HCA Healthcare?

HCA Healthcare currently has 10 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for HCA.

What other companies compete with HCA Healthcare?

Other companies that are similar to HCA Healthcare include Acadia Healthcare, The Ensign Group, Centene, Encompass Health and Elevance Health. Learn More about companies similar to HCA Healthcare.

How do I contact HCA Healthcare's investor relations team?

HCA Healthcare's physical mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company's listed phone number is (615) 344-9551 and its investor relations email address is [email protected]. The official website for HCA Healthcare is www.hcahealthcare.com. Learn More about contacing HCA Healthcare investor relations.